|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wood SL, Pernemalm M, Crosbie PA and
Whetton AD: The role of the tumor-microenvironment in lung
cancer-metastasis and its relationship to potential therapeutic
targets. Cancer Treat Rev. 40:558–566. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fidler IJ: Critical determinants of cancer
metastasis: Rationale for therapy. Cancer Chemother Pharmacol. 43
Suppl:S3–S10. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shimasaki S, Koga M, Esch F, Cooksey K,
Mercado M, Koba A, Ueno N, Ying SY, Ling N and Guillemin R: Primary
structure of the human follistatin precursor and its genomic
organization. Proc Natl Acad Sci USA. 85:pp. 4218–4222. 1988;
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Engel J, Taylor W, Paulsson M, Sage H and
Hogan B: Calcium binding domains and calcium-induced conformational
transition of SPARC/BM-40/osteonectin, an extracellular
glycoprotein expressed in mineralized and nonmineralized tissues.
Biochemistry. 26:6958–6965. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mashimo J, Maniwa R, Sugino H and Nose K:
Decrease in the expression of a novel TGF beta1-inducible and
ras-recision gene, TSC-36, in human cancer cells. Cancer Lett.
113:213–219. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohba M, Shibanuma M, Kuroki T and Nose K:
Production of hydrogen peroxide by transforming growth factor-beta
1 and its involvement in induction of egr-1 in mouse osteoblastic
cells. J Cell Biol. 126:1079–1088. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Johnston IM, Spence HJ, Winnie JN, McGarry
L, Vass JK, Meagher L, Stapleton G and Ozanne BW: Regulation of a
multigenic invasion programme by the transcription factor, AP-1:
Re-expression of a down-regulated gene, TSC-36, inhibits invasion.
Oncogene. 19:5348–5358. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu S, Wang L, Wang W, Lin J, Han J, Sun
H, Guo H, Sun R and Wu Q: TSC-36/FRP inhibits vascular smooth
muscle cell proliferation and migration. Exp Mol Pathol.
80:132–140. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esterberg R, Delalande JM and Fritz A:
Tailbud-derived Bmp4 drives proliferation and inhibits maturation
of zebrafish chordamesoderm. Development. 135:3891–3901. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oshima Y, Ouchi N, Sato K, Izumiya Y,
Pimentel DR and Walsh K: Follistatin-like 1 is an Akt-regulated
cardioprotective factor that is secreted by the heart. Circulation.
117:3099–3108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ouchi N, Oshima Y, Ohashi K, Higuchi A,
Ikegami C, Izumiya Y and Walsh K: Follistatin-like 1, a secreted
muscle protein, promotes endothelial cell function and
revascularization in ischemic tissue through a nitric-oxide
synthase-dependent mechanism. J Biol Chem. 283:32802–32811. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilson DC, Marinov AD, Blair HC, Bushnell
DS, Thompson SD, Chaly Y and Hirsch R: Follistatin-like protein 1
is a mesenchyme-derived inflammatory protein and may represent a
biomarker for systemic-onset juvenile rheumatoid arthritis.
Arthritis Rheum. 62:2510–2516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wei K, Serpooshan V, Hurtado C,
Diez-Cuñado M, Zhao M, Maruyama S, Zhu W, Fajardo G, Noseda M,
Nakamura K, et al: Epicardial FSTL1 reconstitution regenerates the
adult mammalian heart. Nature. 525:479–485. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Adams DC, Karolak MJ, Larman BW, Liaw L,
Nolin JD and Oxburgh L: Follistatin-like 1 regulates renal IL-1β
expression in cisplatin nephrotoxicity. Am J Physiol Renal Physiol.
299:F1320–F1327. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hayakawa S, Ohashi K, Shibata R, Kataoka
Y, Miyabe M, Enomoto T, Joki Y, Shimizu Y, Kambara T, Uemura Y, et
al: Cardiac myocyte-derived follistatin-like 1 prevents renal
injury in a subtotal nephrectomy model. J Am Soc Nephrol.
26:636–646. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Geng Y, Dong Y, Yu M, Zhang L, Yan X, Sun
J, Qiao L, Geng H, Nakajima M, Furuichi T, et al: Follistatin-like
1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling
antagonist in controlling mouse lung development. Proc Natl Acad
Sci USA. 108:pp. 7058–7063. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Y, Han X, Yu Y, Ding Y, Ni C, Liu W,
Hou X, Li Z, Hou J, Shen D, et al: A genetic polymorphism affects
the risk and prognosis of renal cell carcinoma: Association with
follistatin-like protein 1 expression. Sci Rep. 6:266892016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chan QK, Ngan HY, Ip PP, Liu VW, Xue WC
and Cheung AN: Tumor suppressor effect of follistatin-like 1 in
ovarian and endometrial carcinogenesis: A differential expression
and functional analysis. Carcinogenesis. 30:114–121. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Reddy SP, Britto R, Vinnakota K, Aparna H,
Sreepathi HK, Thota B, Kumari A, Shilpa BM, Vrinda M, Umesh S, et
al: Novel glioblastoma markers with diagnostic and prognostic value
identified through transcriptome analysis. Clin Cancer Res.
14:2978–2987. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kudo-Saito C, Fuwa T, Murakami K and
Kawakami Y: Targeting FSTL1 prevents tumor bone metastasis and
consequent immune dysfunction. Cancer Res. 73:6185–6193. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tan X, Zhai Y, Chang W, Hou J, He S, Lin
L, Yu Y, Xu D, Xiao J, Ma L, et al: Global analysis of
metastasis-associated gene expression in primary cultures from
clinical specimens of clear-cell renal-cell carcinoma. Int J
Cancer. 123:1080–1088. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sumitomo K, Kurisaki A, Yamakawa N,
Tsuchida K, Shimizu E, Sone S and Sugino H: Expression of a
TGF-beta1 inducible gene, TSC-36, causes growth inhibition in human
lung cancer cell lines. Cancer Lett. 155:37–46. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bae K, Park KE, Han J, Kim J, Kim K and
Yoon KA: Mitotic cell death caused by follistatin-like 1 inhibition
is associated with up-regulated Bim by inactivated Erk1/2 in human
lung cancer cells. Oncotarget. 7:18076–18084. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shibanuma M, Mashimo J, Mita A, Kuroki T
and Nose K: Cloning from a mouse osteoblastic cell line of a set of
transforming-growth-factor-beta 1-regulated genes, one of which
seems to encode a follistatin-related polypeptide. Eur J Biochem.
217:13–19. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao W, Han HB and Zhang ZQ: Suppression
of lung cancer cell invasion and metastasis by connexin43 involves
the secretion of follistatin-like 1 mediated via histone
acetylation. Int J Biochem Cell Biol. 43:1459–1468. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou X, Xiao X, Huang T, Du C, Wang S, Mo
Y, Ma N, Murata M, Li B, Wen W, et al: Epigenetic inactivation of
follistatin-like 1 mediates tumor immune evasion in nasopharyngeal
carcinoma. Oncotarget. 7:16433–16444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogino H, Yano S, Kakiuchi S, Muguruma H,
Ikuta K, Hanibuchi M, Uehara H, Tsuchida K, Sugino H and Sone S:
Follistatin suppresses the production of experimental
multiple-organ metastasis by small cell lung cancer cells in
natural killer cell-depleted SCID mice. Clin Cancer Res.
14:660–667. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liang X, Hu Q, Li B, McBride D, Bian H,
Spagnoli P, Chen D, Tang J and Zhang JH: Follistatin-like 1
attenuates apoptosis via disco-interacting protein 2 homolog A/Akt
pathway after middle cerebral artery occlusion in rats. Stroke.
45:3048–3054. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen W, Xia J, Hu P, Zhou F, Chen Y, Wu J,
Lei W and Shen Z: Follistatin-like 1 protects cardiomyoblasts from
injury induced by sodium nitroprusside through modulating Akt and
Smad1/5/9 signaling. Biochem Biophys Res Commun. 469:418–423. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang H, Wu S, Huang S, Yin S, Zou G, Huang
K, Zhang Z, Tang A and Wen W: Follistatin-like protein 1
contributes to dendritic cell and T-lymphocyte activation in
nasopharyngeal carcinoma patients by altering nuclear factor κb and
Jun N-terminal kinase expression. Cell Biochem Funct. 34:554–562.
2016. View
Article : Google Scholar : PubMed/NCBI
|
